The recommended procedures – update 12.2.2020
The recommended procedures for submitting correct and complete reporting of marketing authorization holders on the volume of supplies of human medicinal products placed on the market in the Czech Republic (REG-13)
The recommended procedures – update 9.10.2018
The recommended procedures for submitting correct and complete reporting of marketing authorization holders on the volume of supplies of human medicinal products placed on the market in the Czech Republic (REG-13)
Information to fulfill legal obligations of marketing authorisation holders – update 9.10.2018
The State Institute for Drug Control (hereinafter referred to as the “Institute”) wishes to draw the attention to the obligations set out in Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (hereinafter referred to as the “Act on Pharmaceuticals”).
Information to fulfill legal obligations of marketing authorisation holders
The State Institute for Drug Control (hereinafter referred to as the “Institute”) wishes to draw the attention to the obligations set out in Act No 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (hereinafter referred to as the “Act on Pharmaceuticals”).
The recommended procedures
The recommended procedures for submitting correct and complete reporting of marketing authorization holders on the volume of supplies of human medicinal products placed on the market in the Czech Republic (REG-13).